For IFN-γ treatment, Caco-2 cells were incubated in DMEM and 100 U/mL IFN-γ (Sigma–Aldrich; USA) for 48 h. In addition, somatostatin (SST; Sigma–Aldrich; USA) was dissolved in DMEM and added to the culture medium of Caco-2 cells at an experimental concentration of 1 μM 2 h before IFN-γ treatment.
For cell transfection, Tollip siRNAs (siTollip) were constructed by Guangzhou RiboBio Biotechnology Co., Ltd. (Guangzhou; China) and transfected with Lipofectamine® 2000 transfection reagent (Invitrogen; Thermo Fisher Scientific, Inc.; USA) following the instructions. The transfection efficiency was verified by Western blotting 24 h after transfection.